Gilles Raphy

SAR Studies Leading to the Identification of a Novel Series of Metallo-β-lactamase Inhibitors for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections That Display Efficacy in an Animal Infection Model

Simon Leiris, Alicia Coelho, Jérôme Castandet et al. · ACS Infectious Diseases · 2018 · 54 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Development and characterization of a CNS-penetrant benzhydryl hydroxamic acid class IIa histone deacetylase inhibitor

Christopher A. Luckhurst, Omar Aziz, Vahri Beaumont et al. · Bioorganic & Medicinal Chemistry Letters · 2018 · 46 citations

Medicine, Medicinal Chemistry, Pharmacology +9

Design on an affinity-based Nα-amino protecting group for peptide synthesis: tetrabenzo[a,c,g,i]fluorenyl-17-methyl urethanes (Tbfmoc)

R. Ramage, Gilles Raphy · Tetrahedron Letters · 1992 · 39 citations

Pharmacy, Biochemistry, Medicinal Chemistry +9

Development of CXCR3 antagonists. Part 4: Discovery of 2-amino-(4-tropinyl)quinolines

Roland L. Knight, Daniel R. Allen, Helen L. Birch et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 34 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

(17-Tetrabenzo[a,c,g,i]fluorenyl)methylchloroformate (TbfmocCl) a Reagent for the Rapid and Efficient Purification of Synthetic Peptides and Proteins

Angus R. Brown, S.L. Irving, R. Ramage et al. · Tetrahedron · 1995 · 22 citations

Pharmacy, Biochemistry, Biotechnology +12